Fulgent Genetics (FLGT) EBT Margin (2015 - 2026)

Fulgent Genetics has disclosed EBT Margin across 12 years of filings, most recently posting 34.77% for Q2 2026.

• In Q2 2026, EBT Margin fell 846.0% year-over-year to 34.77%; the TTM figure through Jun 2026 stood at 38.36% (down 1863.0% YoY), while the FY2025 annual figure was 21.7%, down 337.0% from the prior year.
• EBT Margin came in at 34.77% for Q2 2026 at Fulgent Genetics, up from 36.52% in the prior quarter.
• In the past five years, EBT Margin ranged from a high of 63.07% in Q1 2022 to a low of 7318.5% in Q4 2025.
• Average EBT Margin over 5 years is 429.49%, with a median of 21.82% recorded in 2023.
• Year-over-year, EBT Margin surged 19538 bps in 2024 and plunged 730794 bps in 2025.
• Over 5 years, EBT Margin stood at 40.03% in 2022, then tumbled by 415 bps to 205.94% in 2023, then surged by 95 bps to 10.56% in 2024, then plunged by 69232 bps to 7318.5% in 2025, then jumped by 100 bps to 34.77% in 2026.
• Per Business Quant data, the three most recent EBT Margin figures were 34.77% in Q2 2026, 36.52% in Q1 2026, and 7318.5% in Q4 2025.